Overview

Study of Danicopan in Participants of Japanese Descent

Status:
Completed
Trial end date:
2020-09-28
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of danicopan after a single-dose oral administration under fed and fasting conditions to participants of Japanese descent.
Phase:
Phase 1
Details
Lead Sponsor:
Alexion Pharmaceuticals